JAMP TOPIRAMATE TABLETS
JAMP TOPIRAMATE TABLETS
Approved
DIN Number
02345250
Drug Class
Human
Market Date
Mar 1, 2023
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02345250
AIG Number0132938001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX11 TOPIRAMATE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
TOPIRAMATEActive
Strength: 25 MG
Monograph: TOPIRAMATE